Recherche
-
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
(Pharmacological Research. pp. 105089, 2020)Article de revue -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 12, pp. 769315, 2021-10-28)Article de revueLibre accès -
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
(Cancers. vol. 14, n° 21, 2022-10-28)Article de revueLibre accès -
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
(Pharmaceuticals (Basel). vol. 17, n° 3, 2024-03-06)Article de revueLibre accès -
Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-05)Article de revue -
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study
(Clinical Genitourinary Cancer. vol. 22, n° 2, pp. 295-304, 2023-11-24)Article de revueLibre accès -
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
(Thérapie. vol. 74, n° 4, pp. 469-476, 2019)Article de revue -
Risk of Serious Trauma with Glucose-Lowering Drugs in Older Persons: A Nested Case-Control Study
(Journal of the American Geriatrics Society. vol. 66, n° 11, pp. 2086-2091, 2018-11)Article de revue